Education
About Us
Working with TipRanks
Follow Us
Hansoo Michael Keyoung Insider Profile
4 Followers
Hansoo Michael Keyoung, Director at CalciMedica, holds 29.08K shares in Kairos Pharma, Ltd. (Ticker: KAPA), holds 1.13M shares in CalciMedica (Ticker: CALC).
Hansoo Michael Keyoung has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Hansoo Michael Keyoung holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Hansoo Michael Keyoung
Hansoo Michael Keyoung's Trading History
CalciMedica
Sep 29, 2020
Director
Uninformative Buy
―
$6.04M
Kairos Pharma, Ltd.
Nov 26, 2025
Director
Uninformative Buy
―
$28.21K
List of latest transactions for each holding click on a transaction to see Hansoo Michael Keyoung's performance on stock
You May Also Like
Hansoo Michael Keyoung insider profile FAQ
What is the percentage of profitable transactions made by Hansoo Michael Keyoung?
The percentage of profitable transactions made by Hansoo Michael Keyoung is ―.
What is the average return per transaction made by Hansoo Michael Keyoung?
The average return per transaction made by Hansoo Michael Keyoung is ―.
What stocks does Hansoo Michael Keyoung hold?
Hansoo Michael Keyoung holds: CALC, KAPA stocks.
What was Hansoo Michael Keyoung’s latest transaction?
Hansoo Michael Keyoung latest transaction was an Uninformative Buy of ―.
What was Hansoo Michael Keyoung's most profitable transaction?
Hansoo Michael Keyoung’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Hansoo Michael Keyoung's role in CalciMedica?
Hansoo Michael Keyoung's role in CalciMedica is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.